Skip to main content
  • About this site
  • Sitemap

Search form

Home
  • Home
  • About
    • Company history
    • Careers
    • Our partners
    • Business development
  • Investor relations
    • The Share
      • Shareholders
      • Analysts
      • Annual General Meeting
      • Acquisitions
      • Account Manager
    • Reports
      • Annual Reports
      • IFRS
    • Presentations
      • Other Presentations
      • Navamedic Investor Day
      • Prospectuses
      • Webcast
    • Corporate Governance
      • Board of Directors
      • Management
      • Articles of Association
    • Financial calendar
    • IR contacts
  • Navamedic generics
  • Vitaflo
  • Newsroom
    • 2011 Archived News
    • 2010 Archived News
    • 2009 Archived News
    • 2008 Archived News
    • 2007 Archived News
  • Contact

Latest news

  • 20.02.2012

    Navamedic ASA: Trades by primary insiders

  • 20.02.2012

    Navamedic ASA: Disclosure of shareholdings

  • 16.02.2012

    Navamedic ASA: Completed Private Placement

  • 09.02.2012

    Navamedic reached another all time high

  • 06.02.2012

    Invitation to presentation of Navamedic's Q4 results on Friday 10 February at 8 a.m

  • 15.12.2011

    Navamedic utvider produktsortimentet

  • 07.12.2011

    Navamedic: Company presentation

  • 02.11.2011

    Navamedic ASA: Allocation of share options

  • 20.10.2011

    Navamedic margins improve while launching generics business

  • 19.10.2011

    Invitation to presentation of Navamedic's Q3-11 results on Friday 21 October at 8 a.m.

  • 12.10.2011

    Navamedics to første generiske legemidler lansert

  • 12.10.2011

    Navamedic: Two first generic drugs launched

Newsroom

  • 2011 Archived News
  • 2010 Archived News
  • 2009 Archived News
  • 2008 Archived News
  • 2007 Archived News
Navamedic ASA
Fornebuveien 42-44
P.O. Box 107
N-1325 Lysaker
Norway
Copyright © 2010 Navamedic ASA
Sitemap
About this site
Contact